Back to Journals » Drug Design, Development and Therapy » Volume 9

Review

Designing biologic selectivity for inflammatory bowel disease – role of vedolizumab

      
Total article views   HTML views PDF downloads Totals
11,516 Dovepress* 9,810+ 2,043 11,853
PubMed Central* 1,706 542 2,248
Totals 11,516 2,585 14,101
*Since 17 December 2014
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 1 1

View citations on PubMed Central and Google Scholar